SD

Swarupa Dutta

Active Director Director DIN 10798088
DIN 10798088 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value •••• Premium profile

About Swarupa Dutta

Data last updated:

Swarupa Dutta is a Director at Hopegen Pharma Private Limited (since 2024). The company operates in Pharma. Hopegen Pharma Private Limited reported revenue of ₹90,720 (FY 2025).

DIN 10798088
Primary Designation Director
Industry Pharma
First Appointment 03 Oct 2024
Oldest Company Age 2 yrs
Largest company Hopegen Pharma Private Limited · ₹90,720 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hopegen Pharma Private Limited U46497OD2024PTC047005
Director03 Oct 20242024₹90,720 (FY 2025)Active

Board colleagues of Swarupa Dutta

NameDINCompanyDesignation
Amit Kumar Dutta10798089Hopegen Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Hopegen Pharma Private Limited
Premium access

Shareholding and investment profile for Swarupa Dutta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Swarupa Dutta

Swarupa Dutta currently holds 1 directorship: Hopegen Pharma Private Limited (Director, since 03 Oct 2024, revenue ₹90,720 (FY 2025)).

Swarupa Dutta was first appointed on 03 Oct 2024 as Director at Hopegen Pharma Private Limited.

The current boards of Swarupa Dutta's companies include Amit Kumar Dutta (Hopegen Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available